Innitius team brings technology expertise and know-how, along with an intimate knowledge of the challenge’s obstetricians face and the solutions they are looking for, which it combines to develop transformative, novel and patented solutions for the market indication. Ruben Molina is a skilled and passionate entrepreneur and an extremely quick learner across the key areas of Innitius' business plan in a time and capital efficient and effective manner. He try to eliminate risk whenever possible.
Threatened Preterm Labor represents one of the main causes of hospitalizations during pregnancy.
The Innitius technology promises to deliver both improved patient care and outcomes as well as a reduction in cost of care for preterm labor patients.
Fine Birth is a real-time and cost-efficient technology which can diagnose false Threatened Preterm labor events. Fine Birth seemto be delivered on a routine basis at a much lower cost than the IVD tests.
INNITIUS is an innovation-driven enterprise with the explicit intent to build competitive advantage based on Fine Birth™, a novel patented diagnostic tool that measures the shear mechanical properties of a pregnant woman’s cervix in order to accurately and cost effectively differentiate between true preterm labor and false preterm labor. Innitius' technology is validated at lab and at real environment. A great example of value proposition from the University of Granada/PTS Granada Cluster/ Andalusian Health System to grow quickly and scale well beyond local markets and aspire to significant growth. INNITIUS understands customer needs, expresses business potential and potential impact on Global Healthcare Systems (emergency departments, maternity wards, and in the US, additionally OB/GYN offices) and addresses the motivation and ambition of Innitius' team and quality of management.
I have been working with Ruben and Innitius for the past 18 months assisting with strategy and business development. Ruben has proven to be a skilled and passionate entrepreneur and an extremely quick learner across the skill spectrum required of a MedTech CEO. He has skilfully directed Innitius and the Fine Birth technology through the "valley of death" and is now directing the company through the regulatory process towards delivering high impact, both clinical and economic, for the critical and growing problem of preterm labor diagnosis. This Innitius technology promises to deliver both improved patient care and outcomes as well as a reduction in cost of care for preterm labor patients.
I sit on the Board of Innitius representing the Mind the Gap fund and I met their CEO, Ruben, even before the company was set up. Ruben is a natural born entrepreneur leading a game-changing startup in the obgyn field. But Innitius also gathers an unsual team of clinical and technology experts that is developping the new concept of "torsional waves", that we expect to have far-reaching consecuences in other clinical fields.
Yes, of course. We at Inveniam Group followed them and made for them the first contacts in the "big world"
Innitius has developed a very interesting technology that could help the pregnant future mother to avoid early birth of her child. Once the technology will conclude the clinical trials phase it could be included as an extra feature of existing obgyn ultrasound equipment as well as in new ones.
The CEO can arrive with it at least until the technology is leased to one of the biggest players in this market today